Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0000899243-16-013892
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-02-19 19:01:17
Reporting Period:
2016-02-17
Filing Date:
2016-02-19
Accepted Time:
2016-02-19 19:01:17
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1623613 Mylan N.v. MYL Pharmaceutical Preparations (2834) 981189497
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1113186 J Douglas Leech Building 4, Trident Place, Mosquito Way
Hatfield, Hertfordshire X0 AL10 9UL
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Ordinary Shares Acquisiton 2016-02-17 11,000 $45.37 42,380 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
Footnotes
  1. Represents the weighted average price of the reporting person's purchase of 11,000 shares in transactions ranging from $45.32 to $45.3765. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.